Results 81 to 90 of about 21,670 (174)
Curcumin, a naturally occurring polyphenol, exhibits significant anti‐inflammatory and antioxidant capabilities. This review elucidates the specific molecular mechanisms by which curcumin exerts therapeutic effects on various diseases, including neurological disorders, cardiovascular diseases, cancers, inflammatory disorders, and autoimmune diseases ...
Lin Wang +15 more
wiley +1 more source
Carvedilol in hypertension treatment
Panagiotis C Stafylas, Pantelis A Sarafidis1st Department of Medicine, AHEPA University Hospital, Aristotle University, Thessaloniki, GreeceAbstract: Although β-blockers have been previously shown to effectively reduce blood pressure (BP) and have ...
Panagiotis C Stafylas +1 more
core
Ziele: Carvedilol ist ein Betablocker der 3. Generation. Noch wenig bekannt ist der Zusammenhang zwischen der Abhängigkeit vom CYP2D6-Polymorphismus auf die Carvedilol-Pharmakokinetik und die Carvedilol-Pharmakodynamik.
Gültepe, Şenol +6 more
core +1 more source
Application of miscibility analysis and determination of Soluplus solubility map for development of carvedilol-loaded nanofibers [PDF]
Electrospinning was used to produce carvedilol-loaded Soluplus polymer nanofibers using a systematic approach. Miscibility between drug and polymer was determined through calculation of the interaction parameter, chi, and the difference between the total
Julijana Kristl +11 more
core +1 more source
HEART FAILURE, DIABETES, BETA-BLOCKERS AND RISK OF HYPOGLYCEMIA
Aim. To evaluate an influence of carvedilol on risk of hypoglycemia in patients with diabetes type 2 (D2) and chronic heart failure (CHF) treated with angiotensin converting enzyme (ACE) inhibitors.Material and methods. 13 patients (10 men, 3 women; aged
A. A. Aleksandrov +6 more
doaj +1 more source
Population pharmacokinetics of carvedilol enantiomers and their metabolites in type-2 diabetes and healthy subjects [PDF]
Carvedilol, a drug available as a racemic mixture, is eliminated as hydroxyphenylcarvedilol (OHC) by CYP2D6 and O-desmethylcarvedilol (DMC) by CYP2C9 followed by conjugation to glucuronides.
Lanchote, VL +3 more
core +1 more source
Schematic representation of the shared pathophysiological mechanisms underlying heart failure (HF) and atrial fibrillation (AF), including inflammation, oxidative stress, endothelial dysfunction, and fibrosis. The figure highlights the clinical and mechanistic convergence of conventional pharmacological therapies and selected nutraceuticals in ...
Laura Beatrice Mattioli +6 more
wiley +1 more source
Abstract Background and aims Cocaine use disorder (CUD) is an increasingly widespread concern worldwide. Various pharmacological treatments have been investigated for CUD, but their efficacy remains unclear, and none have been licensed for treatment.
Craig Paterson +13 more
wiley +1 more source
Comment on Antiarrhythmic effect of carvedilol after acute myocardial infarction: results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN ...
RAZZOLINI, RENATO, Renato Razzolini
core +1 more source
ABSTRACT Background and Aims The applicability of non‐invasive tests (NITs) for clinically significant portal hypertension (CSPH) in patients with hepatocellular carcinoma (HCC) is controversial. We performed a head‐to‐head comparison of various NITs for CSPH and evaluated rule‐in/‐out criteria.
Lorenz Balcar +16 more
wiley +1 more source

